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The purpose of this study was to investigate how CD44 impaired Akt phosphorylation, EGR-1 expression and
cell proliferation. E6.1 Jurkat cells, which lack endogenous CD44 expression, were engineered to express
CD44. Previously we showed that Akt is hypophosphorylated, EGR-1 expression is reduced and proliferation
is impaired in CD44 expressing E6.1 Jurkat cells. The cell cycle was studied using ﬂow cytometry and the role
of calcium (Ca2þ) in Akt phosphorylation and EGR-1 expression was investigated using Western blotting.
Phosphatase activity was assessed using a commercially available kit. CD44 expressing cells showed dis-
ruption at the G1 to S transition. Chelation of Ca2þ from the culture media impaired Akt phosphorylation and
EGR-1 expression in both CD44 expressing cells and the open vector control. Moreover, Ni2þ disrupted cell
proliferation in both cell types suggesting Ca2þ import through calcium release activated calcium channels
(CRAC). Staining of cells with fura-2 AM showed signiﬁcantly higher Ca2þ in CD44 expressing cells as
compared with the vehicle control. Finally, non-calcium mediated phosphatase activity was signiﬁcantly
greater in CD44 expressing cells. We propose that the enhanced phosphatase activity in the CD44 cells
increased the dephosphorylation rate of Akt; at the same time, the increased intracellular concentration of
Ca2þ in the CD44 cells ensured that the phosphorylation of Akt remains intact albeit at lower concentrations
as compared with the vector control. Reduced Akt phosphorylation resulted in lowered expression of EGR-1
and hence, reduced the cell proliferation rate.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
CD44 is a type I transmembrane glycoprotein. Although
classically considered to mediate trafﬁcking via its adhesive in-
teractions with hyaluronan [1–3], CD44 has also been shown to
regulate cell signaling and cell proliferation. CD44 lacks a signaling
domain, however it can facilitate signal transduction by serving as
a platform for molecular recruitment and assembly [4].
Several reports in a variety of cell types have shown that CD44
can augment cell proliferation responses. For example, CD44 can
trigger mobilization of Ca2þ in aortic endothelial cells which in
turn leads to their proliferation [5]. On the other hand, negative
regulation of cell proliferation by CD44 has been reportedB.V. This is an open access article u
00, Camp Bowie Boulevard,
. Mummert).only rarely. Gadhoum et al. showed that CD44 inhibited the pro-
liferation of NB4 cells [6]. More recently, we have evaluated the
proliferation of E6.1 Jurkat cells engineered to express the standard
isoform of CD44 [7]. Importantly, E6.1 Jurkat cells do not en-
dogenously express CD44. We found that CD44 signiﬁcantly re-
duced cell proliferation and down-regulated early growth re-
sponse-1 (EGR-1) protein. EGR-1 is a zinc ﬁnger transcription
factor that can activate the promoters of many genes whose pro-
ducts can inﬂuence cell proliferation [8,9]. Transfection of control
E6.1 Jurkat cells with EGR-1 siRNA also inhibited cell proliferation,
conﬁrming its role. Disruption of the PI3K/Akt pathway with
pharmacological inhibitors reduced EGR-1 expression and cell
proliferation, mirroring the properties of CD44 expressing E6.1
Jurkat cells. Finally, Akt was hypophosphorylated in cells expres-
sing CD44 showing its potential role in negatively regulating Akt
activation. Results from these studies suggested a novel pathway
in which CD44 can negatively regulate cell proliferation by Aktnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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other hand, the mechanism of Akt inactivation was not determined.
Protein phosphatase 2A (PP2A) is known to be an important
regulator of the cell cycle [10]. Moreover, Akt is one of its molecular
targets [11]. Because PP2A has been shown to associate with CD44 in
T cell leukemia [12] we hypothesized that Akt was being inactivated
in CD44 expressing E6.1 Jurkat cells via phosphatase activity. Indeed,
we found that calcium independent phosphatase activity was sig-
niﬁcantly enhanced in the CD44 expressing cells, but not the vector
control cells. At the same time, Ca2þ from the culture environment
ensured that the phosphorylation of Akt remains intact albeit at
lower concentrations as compared with the vector control. Interest-
ingly, Yasuoka et al. has previously reported that Ca2þ may also in-
crease the expression of PP2A [13]. This may further suggest a role
for Ca2þ in both inductive and suppressive proliferative functions in
our system. In conclusion, our results suggest that reduced Akt
phosphorylation due to phosphatase activity resulted in lowered
expression of EGR-1 and hence, reduced the cell proliferation rate in
CD44 expressing E6.1 Jurkat cells.Fig. 1. CD44 expressing Jurkat T cells are arrested in phase G1. (A) Cell cycle ana-
lysis was performed via propidium iodide staining and ﬂow cytometry. Results
show representative data from four repeated experiments. (B) BrdUrd incorpora-
tion was measured in cells synchronized in the G1 phase of the cell cycle after being
allowed to proliferate for 30 min. Results show representative data from four re-
peated experiments. Asterisks indicated statistical signiﬁcance as assessed using
the 2-tailed Student's t-test (*po0.05, **po0.01).
Fig. 2. CD44 expression induces calcium inﬂux. Resting intracellular calcium con-
centration was assessed by ratiometric imaging of fura-2-AM loaded cells. Multiple
images were taken for ratiometric assessment. The asterisk indicates the statistical
signiﬁcance using the 2-tailed Student's t-test (n¼40 cells; **po0.01).2. Materials and methods
2.1. Cell lines and tissue culture
E6.1 Jurkat cells were engineered to express CD44 or an open
vector control as described previously [7]. Expression of CD44 was
conﬁrmed by ﬂow cytometry (Supplementary Fig. 1). Cells were
cultured in RPMI-1640 supplemented with 10% fetal bovine serum,
100 U/mL penicillin, 100 mg/mL streptomycin, 0.25 mg/mL ampho-
tericin B, and 800 mg/mL Hygromycin B. Calcium was removed
from media via ethylene glycol tetraacetic acid (EGTA) chelation at
a concentration of 2.5 mM. LY294002 (Sigma-Aldrich #L9908) was
used at a concentration of 10 mM for 24 h. Wortmannin (Sigma-
Aldrich #W1628) was used at 5 mM for 24 h. Cantharidic acid
(Enzo Life Sciences #BML-PR106-0010) was used at either 100 nM,
250 nM, or 500 nM as indicated for 24 h in Western blotting and
48 h in proliferation experiments.
2.2. Cell cycle analysis
Cells were synchronized by serum starvation for 24 h before
each experiment. One million cells per mL were suspended in 70%
ethanol and incubated at 20 °C for 2 h. Cells were centrifuged and
washed in PBS twice before being incubated in 60 mg/mL propi-
dium iodide (Sigma-Aldrich #P4170) and 10 mg/mL RNase A (Sig-
ma-Aldrich #R6513) for 1 h at 37 °C. Cells were then analyzed via
ﬂow cytometry utilizing a Beckman Coulter Cytomics FC500.
2.3. BrdUrd incorporation
Cells were synchronized in the G1 phase by serum starvation
for 24 h prior to experiments. 5-Bromo-2′-deoxyuridine (BrdUrd)
was added to media at 10 mM and cells were cultured under nor-
mal conditions for 30 min. Samples were stained for BrdUrd ac-
cording to kit manufacturer instructions (BD Biosciences #557891)
before analysis via ﬂow cytometry.
2.4. Proliferation assays
One hundred thousand cells per group were plated into 96 well
plates in 200 mL of media. Cells were allowed to proliferate for 24 h
or 48 h. Proliferation was assessed by 3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetra-
zolium assay (Promega #G5421). To rule out the possibility that an
observed decrease in proliferation was due to a difference inviability, trypan blue staining was performed before and after in-
cubation to assure that viability was maintained throughout the
incubation period. Inducible calcium release activated channel
Fig. 3. CD44 expression induced Ca2þ inﬂux uses CRAC channels to regulate pro-
liferation and Ca2þ is required for proper cell cycling. (A) Cell proliferation with
extracellular calcium, without extracellular calcium, and with Ni2þ , an inhibitor of
CRAC channels under normal extracellular calcium levels. Results are normalized to
percent of the vector control cells with calcium. (B) Cell cycle analysis was per-
formed on CD44 expressing cells via propidium iodide staining and ﬂow cytometry
after incubation in calcium containing (open bars) or calcium free (closed bars)
media for 24 h after synchronization. Asterisks indicate the statistical signiﬁcance
using the 2-tailed Student's t-test (*po0.05).
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2.5. Western blotting
Ten million cells were harvested and lysed with CelLytic M (Sig-
ma-Aldrich #C2978) per the manufacturer's instructions. Protein
concentration was assessed via the Bradford assay and equal amounts
of protein were loaded onto a 4–20% acrylamide gel for sodium do-
decyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Protein
was transferred from SDS-PAGE gels onto nitrocellulose membranes.
Membranes were blocked with 5% non-fat dry milk in Tris-buffered
saline with 0.1% Tween 20 for 2 h before overnight incubation in
primary antibody at 4 °C. EGR-1 was detected at 1:1000 dilution with
anti-hEGR1 antibody (R&D Systems #AF2818). Phospho-Akt was de-
tected at 1:1000 dilutionwith anti-pAkt S473 antibody (Cell Signaling
#9271). Total Akt was detected at 1:1000 with anti-Akt antibody (Cell
Signaling #9272). Beta-actin was used as a loading control and de-
tected at 1:1000 dilution with anti-beta-actin antibody (Cell Signaling
#4967). Blotting with secondary goat anti-rabbit antibodies con-
jugated to alkaline phosphatase (Invitrogen) was performed before
visualization with a UVP GelDoc-It imaging system.
2.6. Intracellular calcium measurements
One million cells per mL were suspended in PBS without cal-
cium. Fura-2-AM was loaded into the cells at 6 mM and thenincubated for 15 min at 37 °C. The suspension was diluted a fur-
ther one fourth with PBS and incubated for 15 min at 37 °C. After
washing, cells were suspended in a buffer containing 140 mM
NaCl, 5 mM KCl, 1 mM MgSO4, 1 mM CaCl2, 20 mM HEPES, 1 mM
NaH2PO4, and 5.5 mM glucose at pH 7.4. Cells were placed on
coverslips coated in poly-L-lysine and incubated for 10 min at 37 °C
before imaging. Intracellular calciumwas measured at 37 °C by the
ratiometric technique using fura-2-AM (excitation at 340 nm and
380 nm, emission at 510 nm) (Invitrogen, Carlsbad, CA) as de-
scribed by utilizing a Nikon Eclipse TE2000-5 microscope and NIS-
Elements AR3.2 software (Nikon Instruments, Melville, NY) [14].
The Grynkiewicz equation was used to convert the 340 nm/
380 nm ratio to internal levels of calcium in nanomolar con-
centrations [15].
2.7. Phosphatase assay
Phosphatase activity in the cells was measured using the kit
from Enzo Life Sciences (#BML-AK804-0001). Brieﬂy, cell protein
extracts were chilled on ice in protease inhibitor lysis buffer. Ex-
tracts were then desalted using a resin column and the amount of
recovered protein was estimated by the Bradford method. Equal
concentrations of proteins were added to wells containing RII
phosphopeptide substrate. Wells containing EGTA were used to
determine calcineurin activity. Results were expressed as nmoles
of phosphate per well after development with BIOMOL Green and
absorption at 655 nm.
2.8. JC-1 mitochondrial staining
One million cells per sample were stained with 5μM JC-1 dye
from Invitrogen (#T3168) by incubating at 37 °C for 15 min. Cells
were spun down and washed once in warm PBS. An ISS PC1
spectroﬂuorometer was used to measure the ﬂuorescence in-
tensity of each cell sample at an ex/em of 485 nm/530 nm for the
monomeric form of JC-1 and an ex/em of 535 nm /590 nm for the
aggregate form of JC-1.
2.9. Statistical analysis
Two groups were compared by the 2-tailed Student's t-test and
more than two groups by the ANOVA with Tukey's multiple
comparisons test. A p-value of less than 0.05 was considered sig-
niﬁcant. All results are shown as the mean7SD. Each experiment
was repeated thrice with similar results in the experiments.3. Results
3.1. CD44 expression causes cell cycle arrest
Our laboratory has previously shown that EGR-1 regulates the
proliferation of E6.1 Jurkat cells and that CD44 expression de-
creases the expression of EGR-1 [7]. The doubling time for CD44
expressing E6.1 Jurkat cells is 34.6770.58 h as compared with a
doubling time of 23.0071.00 h for E6.1 Jurkat cells lacking CD44
expression (values are presented as the means7standard devia-
tions). This signiﬁcant increase in doubling time (Po0.01) is evi-
dence that CD44 signiﬁcantly perturbs E6.1 Jurkat cell prolifera-
tion. Due to EGR-1's importance in regulating the cell cycle [16–19]
we wanted to examine potential dysregulations of the cell cycle
due to CD44 expression. E6.1 Jurkat cells expressing CD44 were
found to have a higher accumulation of cells in the G1/G0 phase of
the cell cycle as compared with the vector control (Fig. 1A). To
determine if there was a deﬁciency in CD44 expressing cells when
progressing through the G1 to S phase checkpoint we directly
Fig. 4. EGR-1 expression is regulated by Ca2þ . (A) Western blot for EGR-1 expression with and without calcium. A representative blot is shown as the left panel and
cumulative densitometry values are shown as the right panel. (B) Cell proliferation before, during, and after a 24 h period without extracellular calcium. Results are
normalized to percent of control cell line with calcium. There was no difference between Vector and CD44 cell lines without calcium (p40.05). (C) Western blotting for EGR-
1 expression before removal of extracellular calcium, after one day of rest following 24 h without extracellular calcium, and after four days of rest following 24 h without
extracellular calcium. A representative blot is shown as the left panel and cumulative densitometry values are shown as the right panel. Densitometry values from three
different Western blots were used to calculate the means 7 SD. Asterisks indicated statistical signiﬁcance using the 2-tailed Student's t-test (A and B) or the ANOVA with
Turkey's multiple comparisons test (C) (*po0.05;**po0.01).
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Vector control and CD44 expressing E6.1 Jurkat cells were syn-
chronized in the G1 phase of the cell cycle and then allowed to
proliferate for 30 min in the presence of BrdUrd. CD44 expressing
cells showed a slower transition from the G1 phase into the S
phase when compared with the vector control cells (Fig. 1B). These
data show that CD44 expression triggers a disruption in cell cycleat the G1 to S phase transition, which is consistent with a decrease
in EGR-1 expression which is a transcription factor responsible for
the expression of early genes within the cell cycle.
3.2. CD44 expression induces calcium inﬂux
Cells were loaded with Fura-2 on poly-L-lysine coated slides in
order to measure their intracellular calcium concentrations. E6.1
Fig. 5. CD44 regulates EGR-1 through Ca2þ signaling and the Akt pathway. (A) Western blot for total Akt and phosphorylated Akt with and without extracellular calcium. A
representative blot is shown as the left panel and cumulative densitometry values are shown as the right panel. (B) Western blot for EGR-1 expression with extracellular calcium
(EC calcium), without EC calcium, with an inhibitor of Akt activation, and without EC calcium and an Akt inhibitor. A representative blot is shown as the left panel and
cumulative densitometry values are shown as the right panels. Densitometry values from three different Western blots were used to calculate the means7SD. Asterisks
indicated statistical signiﬁcance using the 2-tailed Student's t-test (A) or the ANOVA with Turkey's multiple comparisons test (B) (*po0.05).
R.R. Racine et al. / Biochemistry and Biophysics Reports 6 (2016) 172–178176Jurkat cells expressing CD44 were found to have signiﬁcantly more
intracellular calcium as compared with the vector control cells
(Fig. 2, Supplementary Fig. 2). These results showed that CD44
expression disrupts calcium homeostasis.
3.3. CD44 expression induced Ca2þ inﬂux uses CRAC channels to
regulate proliferation and Ca2þ is required for proper cell cycling
To determine if E6.1 Jurkat cells were utilizing Ca2þ release
activated calcium channels (CRAC) for their calcium inﬂux we
cultured cells with the inhibitor, Ni2þ [20–22]. While both CD44
expressing and vector control E6.1 Jurkat cells were both inhibited
by Ni2þ the vector control cells proliferated twice as much as the
CD44 expressing cells. These results show that E6.1 Jurkat cells
require Ca2þ for their proliferation (Fig. 3A). To determine if excess
calcium inﬂux was responsible for the delay in the cell cycle seen
in Fig. 1 we synchronized CD44 expressing E6.1 Jurkat cells and
cultured them with and without extracellular calcium. CD44 ex-
pressing E6.1 Jurkat cells required Ca2þ for their proliferation and
showed signiﬁcantly greater death rates without Ca2þ (i.e., the
increased sub-G1 phase of the cell cycle; Fig. 3B).
3.4. EGR-1 expression is regulated by Ca2þ
EGR-1 expression is regulated in part by Ca2þ signaling [23,24].
In order to determine if EGR-1 is regulated by calcium in E6.1
Jurkat cells, we cultured them and the vector control cells with
and without Ca2þ . EGR-1 expression was reduced in both vector
control cells and CD44 expressing cells (Fig. 4A), indicating that
Ca2þ is required for EGR-1 expression. Upon culture in mediawithout Ca2þ for 24 h, both CD44 expressing and vector control
cells proliferated less than those cultured in the presence of Ca2þ
(Fig. 4B). In order to determine if this decrease in proliferation due
to Ca2þ deprivation was a permanent or transient effect, we re-
stored Ca2þ to cells which had been deprived of extracellular
Ca2þ . After one day of restored Ca2þ in the media, both the CD44
expressing and vector control E6.1 Jurkat cells showed prolifera-
tion equivalent to cells without available Ca2þ (Fig. 4C). These
results indicate that Ca2þ is required for both the vector control
and CD44 expressing E6.1 Jurkat cells. After four days of restored
Ca2þ , EGR-1 expression proliferation returned to its baseline in
both CD44 expressing and vector control cells (Fig. 4D). These data
show that Ca2þ is required for EGR-1 expression and proliferation.
3.5. CD44 regulates EGR-1 through Ca2þ signaling and the Akt
pathway
To investigate the possibility that CD44 expression regulates
Akt phosphorylation through Ca2þ signaling, we cultured cells
with and without Ca2þ and measured the phosphorylation of Akt.
As we have previously shown, Akt was hypophosphorylated in
cells expressing CD44 under normal conditions [7]. When Ca2þ
signaling is removed through chelation with EGTA, both the vector
control cells and CD44 expressing Jurkat T cells have hypopho-
sphorylated Akt (Fig. 5A). The observed decrease due to the re-
moval of calcium was proportional in each cell line, with both
control and CD44 expressing cells having approximately half as
much phosphorylated Akt.
To determine if Akt regulation of EGR-1 expression occurs up-
stream or downstream of Ca2þ based EGR-1 expression, we cultured
Fig. 6. CD44 increases phosphatase activity in E6.1 Jurkat cells. (A) A phosphatase activity assay speciﬁc for PP1, PP2A, calcineurin, and PP2C. Total represents all measured
phosphatase activity. Calcium Independent (Calcium Ind.) is the activity of PP1, PP2A, and PP2C. CaN is the activity of just calcineurin. (B) Western blot for total Akt and
phosphorylated Akt with cantharidic acid. The Western blot was repeated 3 times with similar results. (C) Proliferation of cells with different concentrations of cantharidic
acid over 48 h. Results are normalized to untreated vector control cells. (D) JC-1 staining for mitochondrial depolarization as measured by ﬂow cytometry (left panel) and
spectroﬂuorometry (right panel). Results are expressed as the ratio of red mitochondrial associated dye to green cytosol associated dye. Asterisks indicated statistical
signiﬁcance using the 2-tailed Student's t-test (A) or the ANOVA with Turkey's multiple comparisons test (C) (*po0.05).
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tracellular calcium. Importantly, LY294002 was non-toxic to cells.
Moreover, Wortmannin provided similar results as previously re-
ported [7]. EGR-1 expression was reduced in control and CD44 ex-
pressing Jurkat cells in response to lack of extracellular Ca2þ , Akt
inhibition, and both the lack of extracellular Ca2þ and Akt inhibition
(Fig. 5B). We interpret these data to suggest that CD44 expression
results in decreased Ca2þ mediated Akt phosphorylation through
another mechanism, potentially increased phosphatase activity.
3.6. CD44 increases phosphatase activity in E6.1 Jurkat cells
In the above experiments, Ca2þ was shown to play a role in both
EGR-1 expression and Akt phosphorylation. Because CD44 expres-
sing cells showed signiﬁcantly higher concentrations of Ca2þ , how
can we explain Akt hypophosphorylation and reduced EGR-1 ex-
pression? Rajasagi et al. has shown that CD44 is associated with the
expression of phosphatase enzymes [12]. We therefore hypothesized
that CD44 expressing E6.1 Jurkat cells could potentially express
higher activities of phosphatases. As shown in Fig. 6A, total phos-
phatase activity was signiﬁcantly higher in CD44 expressing cells as
compared with the vector control. Calcineurin, which is a Ca2þ de-
pendent phosphatase did not have signiﬁcantly different activities
between the CD44 expressing and non-expressing cells. Yasuoka
et al. showed that elevated Ca2þ levels in myocardiac H9c2 cells
decreases the activation of Akt by inducing PP2A expression and
activity [13]. Similarly, as shown in Fig. 6B, we found that use of the
PP2A inhibitor cantharidic acid resulted in increased phosphorylation
of Akt after 24 h in CD44 expressing cells, but not the vector control
cells. Inhibition of PP2A with cantharidic acid also rescued the pro-
liferation of CD44 expressing E6.1 Jurkat cells, and the increase inproliferation over the control baseline is not observed in similarly
treated vector control cells (Fig. 6C). Finally, the manuscript by Ra-
jasagi et al. also shows that CD44 association with PP2A in EL4 T
lymphoma cells results in apoptosis via mitochondrial depolarization
[12]. By contrast, we found that CD44 expression in Jurkat E6.1 cells
does not induce apoptosis [7] nor does it impact mitochondria po-
larization [12] (Fig. 6D). Thus, CD44 appears to have different effects
based on the genetic background of the cell type under investigation.4. Discussion
We previously have shown that expression of CD44 in Jurkat E6.1
cells signiﬁcantly impaired cell proliferation by reducing Akt activa-
tion and EGR-1 expression. The purpose of these current studies was
to determine the mechanism whereby CD44 inactivates Akt, down-
regulates EGR-1 and impairs cell proliferation. Here, we advance our
previous studies by showing that CD44 expression enhances the
uptake of Ca2þ and increases the activity of phosphatase enzymes.
Chelation of Ca2þ signiﬁcantly reduced Akt phosphorylation and
EGR-1 expression in both CD44 expressing and control vector cells.
Although it is also possible that EGR-2 and EGR-3, which can serve as
negative regulators for EGR-1 expression play a role in its expression,
our ﬁnding that LY294002 impairs EGR-1 expression strongly sug-
gests that the PI3K/Akt pathway is the major pathway for EGR-1
expression in E6.1 Jurkat cells. CD44 expressing E6.1 Jurkat cells
showed an increase in the S phase of the cell cycle when the ex-
tracellular calcium was removed and increased cell death. This result
provides further support to Fig. 3A, reinforcing the notion that ex-
tracellular Ca2þ is required for proliferation in CD44 expressing E6.1
Jurkat cells. Finally, cell proliferation was signiﬁcantly impaired by
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that Ca2þ is responsible for the Akt mediated expression of EGR-1 in
both CD44 expressing and vector control Jurkat E6.1 cells and for
their proliferation.
Analyses showed that CD44 dysregulated Ca2þ homeostatsis as
compared with the vector control cells. The concentration of in-
tracellular Ca2þ in CD44 expressing cells was nearly three times
higher than the intracellular concentration of Ca2þ in vector control
cells. Because Ca2þ was shown to be requisite for Akt phosphoryla-
tion and EGR-1 expression it would seem reasonable to postulate
that CD44 expressing cells should have higher concentrations of ac-
tivated Akt and EGR-1 and proliferate at a greater rate than vector
control cells. On the contrary, we have observed that Akt was hy-
pophosphorylated and EGR-1 expression was reduced in CD44 ex-
pressing cells. At the same time, we also found a signiﬁcant increase
in the activities of phosphatases in the CD44 expressing cells. The
phosphatase PP2A has been immunoprecipitated with CD44 in EL4 T
lymphoma cells and cross-linkage of CD44 has been shown to acti-
vate PP2A in EL4 T lymphoma cells [12]. Increased intracellular cal-
cium has been shown in H9c2 myocardiac cells to increase the ex-
pression and activity of PP2A, resulting in decreased Akt phosphor-
ylation [13]. We found that inhibition of PP2A with cantharidic acid
resulted in increased phosphorylation of Akt similar to the vector
control cells. Cantharidic acid had no overall effect on the phos-
phorylation of Akt in the control cells, suggesting a CD44 speciﬁc
effect on PP2A activity. We propose that the increased phosphatase
activity in the CD44 cells increases the dephosphorylation rate of Akt.
Previous investigations have shown that phosphatases can directly
dephosphorylate Akt [25,26]. At the same time, the increased in-
tracellular concentration of Ca2þ in the CD44 cells ensures that the
phosphorylation of Akt remains intact albeit at lower concentrations
as compared with the vector control cells. We propose that the lower
concentration of active Akt in the CD44 expressing cells results in
lower concentrations of EGR-1, hence reduced proliferation rates.
E6.1 Jurkat cells are a T cell lymphoblastic leukemia line. Previous
investigations have shown that there is a link between CD44 expres-
sion and T cell lymphoblastic leukemia. Cavalcanti et al. found that
CD44 expression was detected in 77% of patients with disease and was
correlated with mediastinal mass, adrenomegaly, inﬁltration of the
central nervous system and other organs. This group proposed that
CD44 could be regarded as a marker for tissue inﬁltration in T cell
leukemia [27]. Similarly, Viskova et al. found that high levels of CD44
expression were linked to a highly aggressive subtype of acute lym-
phoblastic leukemia [28]. Khan et al. found that CD44 surface expres-
sion predicted relapse in children with acute lymphoblastic leukemia
[26]. More recently Kamazani et al. found that CD44 expression in
acute lymphoblastic leukemia was correlated with higher white blood
cell counts, a higher percentage of blast cells in the bone marrow, and
that CD44 expression could serve as predictor of responsiveness to
therapy [27]. Although we currently do not know the impact of CD44
expression on the in vivo lethality of E6.1 Jurkat cells, current experi-
ments in mice are planned in our laboratory to determine its effect.
In conclusion, we have reported a unique functional role for
CD44 in regulating cell proliferation. Results and experimental
systems described in this study provide the technical and con-
ceptual foundation for further investigating the role of CD44 in cell
proliferation. Future experiments showing the effect of CD44 ex-
pression in vivo may elucidate the mechanistic relationship be-
tween CD44 expression in acute lymphoblastic leukemia and the
negative outcomes associated with CD44 in clinical studies.Appendix A. Transparency document
Transparency document associated with this article can be found
in the online version at http://dx.doi.org/10.1016/j.bbrep.2016.03.016.References
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